Cohen Development Co v. JMJ Properties Inc ( 2003 )


Menu:
  •                           In the
    United States Court of Appeals
    For the Seventh Circuit
    ____________
    No. 01-3443
    COHEN DEVELOPMENT COMPANY,
    an Illinois corporation,
    Plaintiff-Appellant,
    v.
    JMJ PROPERTIES, INC.,
    a Michigan corporation,
    Defendant-Appellee.
    ____________
    Appeal from the United States District Court
    for the Central District of Illinois.
    No. 00 C 2123—Michael P. McCuskey, Judge.
    ____________
    ARGUED MAY 31, 2002—DECIDED JANUARY 24, 2003
    ____________
    Before HARLINGTON WOOD, JR., COFFEY, and ROVNER,
    Circuit Judges.
    ROVNER, Circuit Judge. Cohen Development Company
    (“CDC”) and JMJ Properties, Inc. failed to jointly acquire
    a piece of property in Albertville, Minnesota, on which
    they hoped to develop an outlet mall. CDC then sued JMJ,
    in part, for breach of a contract that the parties allegedly
    had entered into to acquire the land. Following a bench
    trial, the district court held that CDC failed to prove
    that the parties had entered into an enforceable agree-
    ment, and entered judgment in favor of JMJ. CDC appeals,
    and we affirm.
    2                                               No. 01-3443
    BACKGROUND
    1. Facts
    CDC, a family-owned business, develops, owns, and
    manages shopping centers and hotels. In 1994 Leslie
    Cohen, then Executive Vice President of CDC, identified
    an approximately 135-acre parcel of property along In-
    terstate 94 in Albertville that he thought was the “last
    great” site in the Midwest for the development of a retail
    outlet mall and complementary development. In January
    1995 CDC entered an Option Agreement with the prop-
    erty’s owners, Judith and Bernard Roden, that gave CDC
    the exclusive opportunity to purchase the property for
    $733,848. The Option Agreement initially expired May 1,
    1995, but gave CDC the right to extend its option in six-
    month intervals through November 1, 1997. After acquir-
    ing the option, CDC developed a master plan for the
    property under which 60 acres would be developed as an
    outlet shopping center and the remaining 75 acres for
    complimentary retail, light industrial, and warehouse
    use. Because, as Cohen testified at trial, CDC policy was
    to develop shopping centers on a nonrecourse basis, that
    is, without personal financial liability to CDC’s principals,
    he was interested in finding a partner to develop the out-
    let portion of the property.
    A. The Parties’ Original Purchase Agreement
    In September 1995 Cohen attended a semiannual con-
    vention held by Value Retail News (“VRN”), an industry
    trade organization for developers of outlet malls, where
    he was introduced to James Morse, Jr., the president of
    JMJ. Cohen and Morse discussed CDC’s interest in “flip-
    ping” or selling 60 acres of the Roden property for the
    development of a retail mall while retaining the remain-
    ing 75 acres. Morse and Cohen reached a handshake deal
    for CDC to sell 60 acres to JMJ once it acquired the Roden
    No. 01-3443                                              3
    property, and on October 24, 1995, CDC and JMJ executed
    a Purchase Agreement memorializing their understand-
    ing. Under the Agreement, which was valid for one year,
    JMJ agreed to purchase from CDC 60 acres of the Roden
    property for $1,050,000, subject to certain contingencies,
    and to pay CDC earnest money of $5,000 per month dur-
    ing the term of the Agreement. The parties amended the
    Agreement in March 1996 to provide that JMJ would
    by July 1, 1996, designate specifically in writing the land
    it would purchase (that designation was necessary be-
    cause at the time the Agreement was signed, CDC and
    JMJ had allowed the boundary of the 60 acres to “float”
    within the entire 135-acre parcel due to wetland mitiga-
    tion issues). In August JMJ identified the parcel it would
    purchase.
    During 1996 JMJ attempted to pre-lease space in the
    outlet mall (before developers begin construction on a
    mall, they prefer to have 50-70% of the planned store space
    pre-leased). Leasing progressed slowly, however, and in
    June and July 1996 Morse and Cohen discussed extend-
    ing the Purchase Agreement so that JMJ would have
    extra time to market the property. At another VRN con-
    ference in the fall of 1996, Cohen presented to Morse a
    second amendment to extend the Purchase Agreement.
    Morse reviewed the draft with his attorneys but rejected
    it in a November 11 letter to Cohen because the changes
    and additions it made to the original Purchase Agree-
    ment were “too substantial to consider.” Around this time
    Cohen also met with the Rodens to try to extend the Op-
    tion Agreement beyond November 1997, but they re-
    fused. JMJ and CDC failed to agree to an extension of
    the Purchase Agreement, and it expired in November
    1996. Although CDC and JMJ continued to negotiate after
    the Agreement expired, CDC also explored options with
    other developers to purchase the Roden property. Over-
    tures made in January 1997 to Insignia Commercial In-
    vestments Group, for instance, proved unsuccessful.
    4                                               No. 01-3443
    B. The Alleged 1997 Agreement
    In a February 1997 telephone conversation, Morse
    informed Cohen that the Rodens would not sign another
    option agreement with CDC, but he believed they would
    do so with JMJ. In an April 3 letter to Morse, Cohen noted
    that the Purchase Agreement had expired in November
    1996 and stated that “you [Morse] and I have discussed the
    potential ways our companies . . . may now be able to
    reach a new agreement,” but noted that “each time we
    sent you a written agreement, you tell me you have re-
    considered the terms of our verbal understanding, have
    ‘changed your mind’, or otherwise refused to proceed.”
    Cohen further asked Morse to “provide to [CDC] a care-
    fully considered offer in writing, one with which you are
    comfortable,” and stated:
    I trust you agree that time is of the essence in deter-
    mining, for each of us, the future coarse [sic] of the
    development and ownership of this project. I think
    we have been most patient in the past several months
    in waiting for a formalized agreement, and I do not
    see how we can protract this process much further.
    Accordingly, I ask that you provide a red-line or sum-
    mary of what we can later incorporate into a more
    formal written agreement.
    On April 8 Morse responded to Cohen’s letter. He ex-
    plained that with CDC’s cooperation he could secure a long-
    term option on the Roden property, and that the par-
    ties would then have what they originally agreed to:
    At this point, I believe our best course of action would
    be to determine how to secure a longer term option
    without either of us losing our previously agreed
    upon development interests. This can be accomplished,
    however, your full cooperation will be a necessity. Al-
    low me to go make the business deal on the land and
    No. 01-3443                                              5
    you will have what was originally agreed to, as will
    we. The only difference being we have a long-term
    option.
    Although this letter was written on JMJ letterhead and
    contained Morse’s signature, Morse did not sign the let-
    ter himself. CDC did not introduce at trial any evidence
    to establish who actually signed the letter, although
    Cohen testified that he believed it was signed by Morse’s
    secretary.
    On May 6, Cohen responded to Morse’s letter, stating
    that “we have agreed to accept your [April 8, 1997] offer.”
    He also summarized his understanding of the deal, which
    was that CDC would allow JMJ to reach an agreement
    with the Rodens to purchase their property, and JMJ would
    then transfer 75 acres and $225,000 to CDC:
    It is our understanding that we will allow you to make
    the business deal on the property, as you proposed.
    In so doing, you and I will each end up with the re-
    spective interests previously agreed upon, as follows:
    immediately upon your purchase of the property, you
    will retain sixty acres for your retail development
    and will then convey, or cause to be conveyed to us, to
    us [sic] the residual seventy five acres along with a
    $225,000 net cash profit.
    Cohen testified at trial that in a subsequent telephone
    conversation, Morse assured Cohen that they would pro-
    ceed according to the understanding outlined in Cohen’s
    May 6 letter. After Cohen’s May 6 letter, CDC refrained
    from contacting the Rodens to either exercise or extend
    its Option, though it did discuss the Roden property with
    other developers and investors in case the agreement
    with JMJ fell through.
    6                                             No. 01-3443
    C. Further Discussions Between JMJ and CDC
    in Fall 1997
    In September 1997 Morse informed Cohen that JMJ
    and the Rodens had agreed to a two-year option agreement
    for the Roden property, under which JMJ would pay the
    Rodens $20,000 per year earnest money for the right to
    purchase the property for $900,000. Morse also told Cohen
    that he believed that JMJ owed CDC $225,000 (the net
    profit CDC would have realized if JMJ had purchased
    the 60 acres for $1,050,000 as contemplated under the
    parties’ original Purchase Agreement) and that he wanted
    to put a formal agreement together to accommodate a
    transaction between JMJ and CDC. In October Morse
    faxed a letter to Cohen stating that if all went well, he
    would execute the option agreement with the Rodens by
    October 10, 1997. He further stated that “of course, simul-
    taneous to this, you and I must execute an agreement
    whereby you will receive from me 75± acres of the 135±
    acres for $1.00.” Morse enclosed a draft agreement for
    Cohen’s review, noting that JMJ and CDC had entered
    into the October 1995 Purchase Agreement on the basis
    of the Option Agreement held by CDC to purchase the
    Roden property and that CDC’s Option Agreement was
    due to expire on November 1, 1997. It further stated
    that CDC and JMJ had “agreed to certain changes in their
    prior relationship and certain revisions to their mutual
    undertakings” and provided the following terms: 1) CDC
    would not seek to renew, extend, or revise its Option
    Agreement with the Rodens; 2) JMJ would exert its best
    efforts to obtain a new two-year option agreement from
    the Rodens, and CDC would transfer its right, title, and
    interest in its 1995 Option Agreement to JMJ; 3) JMJ
    would waive its right to seek specific performance of the
    1995 Purchase Agreement as long as CDC did not de-
    fault on any of its terms; and 4) if JMJ successfully exer-
    cised an option agreement with the Rodens and acquired
    No. 01-3443                                                7
    the 135 acres of property, it would transfer 75 acres of the
    property to CDC for $1.00.
    On October 24, 1997, Cohen wrote Morse back, stating
    that CDC “accept[s] the new agreement for [the Roden
    property] which you sent to me.” Cohen did not, however,
    sign and return the proposed agreement—rather, he told
    Morse that “[t]here remains some minor ‘clean-up’ lang-
    uage and exhibits which our counsel will provide in a
    follow-up letter next week, all of which will assist your
    final revision of our Agreement for immediate signature.”
    CDC’s attorneys sent various suggested revisions to Morse,
    but no finalized agreement was ever signed by both JMJ
    and CDC. On October 31, Cohen sent a letter to the Rodens
    advising them that CDC would not exercise its Option
    to purchase their land; CDC’s Option expired the follow-
    ing day. On November 5, JMJ entered into an option agree-
    ment with the Rodens to purchase an approximately 105-
    acre portion of their land for $850,000. JMJ exercised the
    option in April 1999. It did not sell any of the land to CDC,
    but instead developed an outlet mall on the property
    without CDC’s involvement.
    2. District Court Proceedings
    In December 1999 CDC (an Illinois corporation) filed
    this diversity suit against JMJ (a Michigan corporation),
    Morse (a Michigan citizen), and the Rodens (Minnesota
    citizens, who were subsequently dismissed) seeking a
    declaratory judgment setting forth the parties’ rights to
    the Rodens’ land and asserting that JMJ and Morse had
    committed fraud against CDC, breached fiduciary duties
    they owed to CDC, and tortiously interfered with CDC’s
    8                                                 No. 01-3443
    business relationships.1 Morse passed away during the
    pendency of the suit. In June 2000 CDC amended its
    complaint against JMJ and Morse’s estate (which was
    later voluntarily dismissed), substituting a breach of con-
    tract claim for the declaratory judgment action.
    The district court held a bench trial in November 2000
    and granted judgment in favor of JMJ in August 2001. At
    trial CDC argued that the exchange of letters between it-
    self and JMJ on April 8 and May 6, 1997, evidenced a
    valid contract between the parties. JMJ argued that the
    parties had not reached an agreement and that the let-
    ters did not meet the requirements of the Illinois Frauds
    Act, 740 ILCS 80/2. The district court agreed with JMJ,
    finding that there was no “final, enforceable written
    agreement between [CDC and JMJ that] satisfies the
    Frauds Act.” The court concluded that even if the exchange
    of letters in Spring 1997 did establish a valid written
    contract between the parties, the agreement it contained
    was no longer recognized as effective by the parties in
    September 1997. In reaching this conclusion, the court
    relied upon the communications between Cohen and
    Morse in September in which both acknowledged the
    need to enter a formal agreement regarding the Roden
    property; the court found that these communications re-
    flected that neither JMJ nor CDC “believed they had a
    finalized agreement at that time.” Thus, the court found,
    the evidence showed that JMJ did not intend to be bound
    by the Spring 1997 exchange of letters. The court addi-
    1
    The parties and the district court applied Illinois law in an-
    alyzing CDC’s claims, and both parties have argued Illinois law
    on appeal. We therefore also apply Illinois law in our analysis.
    See Rosenblum v. Travelbyus.com Ltd., 
    299 F.3d 657
    , 662 n.2
    (7th Cir. 2002); Brunswick Leasing Corp. v. Wisconsin Central,
    Ltd., 
    136 F.3d 521
    , 525-26 (7th Cir. 1998).
    No. 01-3443                                               9
    tionally concluded that the parties did not reach such a
    formal agreement because Cohen never signed the draft
    sent by Morse but rather proposed “substantive” changes
    to it that were not agreed to by JMJ. Thus, CDC’s breach
    of contract claim was barred by the statute of frauds.
    The court also rejected CDC’s argument that the stat-
    ute of frauds was inapplicable because CDC had fully per-
    formed the alleged Spring 1997 agreement by not contact-
    ing the Rodens either to extend the Option Agreement
    or to exercise its Option to purchase the property. The
    court found that any performance by CDC was “complete-
    ly illusory” because CDC had continued to pursue a pur-
    chase of the property independent of JMJ and had not
    contacted the Rodens for reasons other than its supposed
    agreement with JMJ.
    DISCUSSION
    CDC argues that the district court erred in conclud-
    ing that its breach of contract claim was prohibited by
    the Illinois statute of frauds. It asserts that the district
    court wrongly determined that no enforceable written
    contract that complied with the statute of frauds existed
    between the parties and, in any event, that the statute
    of frauds did not apply to the agreement between the
    parties. Because the district court rendered judgment
    after a bench trial, we review its legal conclusions de novo
    and its findings of fact and its application of facts to law
    for clear error. See Fed. R. Civ. P. 52(a); Hess v. Hartford
    Life & Accident Ins. Co., 
    274 F.3d 456
    , 461 (7th Cir. 2001).
    A finding is clearly erroneous only when this court “is
    left with a definite and firm conviction that a mistake
    has been committed.” Bowles v. Quantam Chemical Co.,
    
    266 F.3d 622
    , 630 (7th Cir. 2001) (citations omitted).
    10                                                    No. 01-3443
    1. Existence of Enforceable Contract
    A. Intent to Enter Contract
    CDC first contends that the district court erroneously
    concluded that no enforceable contract existed between
    itself and JMJ. It asserts that the exchange of letters
    in April and May 19972 manifested the parties’ intent to
    form a binding agreement and that the court improp-
    erly determined that the parties’ subsequent negotiations
    in September 1997 to enter a more formal agreement
    negated that agreement as a matter of law. Whether CDC
    and JMJ intended to enter into a contract is a factual issue
    which we review for clear error. Ginsu Prods., Inc. v. Dart
    Indus., Inc., 
    786 F.2d 260
    , 262 (7th Cir. 1986); see also City
    of El Centro v. United States, 
    922 F.2d 816
    , 820 (Fed. Cir.
    1990); Bay Area Typographical Union, Union No. 21 v.
    Alameda Newspapers, Inc., 
    900 F.2d 197
    , 199 (9th Cir.
    1990). To determine whether the parties intended to be
    bound by the alleged contract, we look not to the parties’
    subjective intent but rather to objective evidence of their
    intent. Empro Mfg. Co. v. Ball-Co Mfg., Inc., 
    870 F.2d 423
    ,
    425 (7th Cir. 1989). When parties make a pact “subject
    to” the execution of a later agreement, they manifest an
    intent not to be bound by the original pact. Id.; see also
    Chicago Inv. Corp. v. Dolins, 
    481 N.E.2d 712
    , 715 (Ill.
    1985).
    2
    In its brief, JMJ argues that the April 8 and May 6 letters
    were not admitted into evidence by the district court and should
    not be considered on appeal because they are inadmissible hear-
    say. The district court in fact declined to rule on their admissibil-
    ity because “even considering [them], CDC has not shown the
    existence of a written contract binding on JMJ.” We too need
    not address the admissibility of these documents because even
    taking them into account CDC fails to show that the district
    court committed any error in its decision.
    No. 01-3443                                               11
    The evidence presented at trial supports the district
    court’s factual determination that CDC and JMJ did not
    intend to be bound by the Spring 1997 exchange of let-
    ters. First, it is not clear that Morse intended his April 8
    letter to constitute an offer to Cohen to enter a contract.
    In the letter Morse suggested that Cohen “allow me to go
    make the business deal on the land and [CDC] will have
    what was originally agreed to, as will [JMJ].” CDC’s as-
    sertion that this statement constituted a “specific offer”
    reads more into Morse’s words than is reasonable. Morse
    prefaced the “offer” with language more indicative of a
    willingness to bargain than an invitation to contract,
    stating that “I believe our best course of action would be
    to determine how to secure a longer term option with-
    out either of us losing our previously agreed upon develop-
    ment interests.” Furthermore, his “offer” was vague, fail-
    ing to set forth any specific obligations the parties would
    undertake, and was qualified by language more consis-
    tent with an invitation to bargain than an offer to enter
    a contract. Rather than asking Cohen to indicate whether
    he accepted the terms of the “offer,” Morse’s letter stated,
    “Les, the ball is in your court” and “[p]lease give me a call
    at your earliest convenience,” indicating that further dis-
    cussion was necessary. Cohen thus failed to establish that
    Morse’s April 8 letter constituted an offer to contract.
    Additionally, the exchange of documents reflects that
    both JMJ and CDC intended to enter a formal agreement
    setting forth their relationship and respective obliga-
    tions with respect to purchasing the Roden property. Be-
    fore Morse made his April 8 “offer” to Cohen, Cohen in an
    April 3 letter had expressed impatience waiting for the
    parties to enter a “formalized agreement” and had invited
    Morse to provide “a red-line or summary of what we can
    later incorporate into a more formal written agreement.”
    Furthermore, although Cohen in his May 6 letter pur-
    ported to accept Morse’s “offer,” the parties continued to
    12                                             No. 01-3443
    negotiate the terms of a formal agreement until CDC’s
    Option expired, further indicating that they had not
    reached an agreement in, or intended to be bound by, the
    Spring 1997 letters. In light of this evidence, we cannot
    say that the district court clearly erred in finding that
    JMJ and CDC did not intend for the exchange of letters
    to form a binding written contract.
    Because we agree with the district court’s finding
    that CDC and JMJ did not intend to enter a binding
    agreement via their exchange of letters, we need not con-
    sider CDC’s argument that subsequent negotiations did
    not render that agreement void.
    B. Conformity with the Statute of Frauds
    CDC also argues that the district court erroneously
    concluded that its purported agreement with JMJ did not
    conform with the Illinois statute of frauds. It asserts that
    even though there was “no single document that was
    signed by both parties agreeing to the terms and condi-
    tions,” the Spring 1997 exchange of letters sufficiently
    enumerated the basic terms of the parties’ agreement. The
    Illinois statute of frauds provides that actions regarding
    a sale of land are barred unless the land sale agreement
    is memorialized in writing:
    No action shall be brought to charge any person upon
    any contract for the sale of lands . . . unless such
    contract or some memorandum or note thereof shall
    be in writing, and signed by the party to be charged
    therewith, or some other person thereunto by him
    lawfully authorized in writing, signed by such party.
    740 ILCS 80/2. The writing required by the statute need
    not itself be a valid contract, but only evidence of one.
    Crawley v. Hathaway, 
    721 N.E.2d 1208
    , 1211 (Ill. App. Ct.
    1999) (quoting Melrose Park Nat’l Bank v. Carr, 618
    No. 01-3443                                               
    13 N.E.2d 839
    , 843 (Ill. App. Ct. 1993)). To satisfy the statute
    of frauds, however, a written memorandum must contain
    on its face the names of the vendor and vendee, a descrip-
    tion of the property sufficient to define it as the subject
    matter of the contract, the price and other terms and
    conditions of the sale, and the signature of the party to be
    charged. Crawley, 
    721 N.E.2d at 1210
     (quoting Callaghan
    v. Miller, 
    162 N.E.2d 422
    , 424 (Ill. 1959)). A writing can
    satisfy the statute even if it is made up of several docu-
    ments, such as notes, papers, or letters as long as, taken
    together, they contain the required information either
    on their face or by reference to other writings. American
    Coll. of Surgeons v. Lumbermens Mut. Cas. Co., 
    491 N.E.2d 1179
    , 1192 (Ill. App. Ct. 1986).
    Even if CDC and JMJ had manifested an intent to be
    bound by the Spring 1997 exchange of letters, those let-
    ters did not meet the mandates of the statute of frauds.
    Most notably, CDC presented no evidence that either of
    the letters was signed by an authorized agent of JMJ, the
    party to be charged under the contract. See Prodromos v.
    Poulos, 
    560 N.E.2d 942
    , 946 (Ill. App. Ct. 1990). It is
    undisputed that Morse, JMJ’s president, did not sign the
    April 8 letter that JMJ sent to Cohen. Although Cohen
    testified at trial that the signature “appears to be the
    signature of [Morse’s] secretary,” he could not definitively
    identify who had signed the document. But even if the let-
    ter had been signed by Morse’s secretary, CDC presented
    no evidence that she had written authority to sign an
    agreement with CDC. See Leekha v. Wentcher, 
    586 N.E.2d 557
    , 560 (Ill. App. Ct. 1991) (agent must have written
    authority to sign contract for sale of land) (quoting
    Prodromos, 
    560 N.E.2d at 946
    ); Schoenberger v. Chicago
    Transit Auth., 
    405 N.E.2d 1076
    , 1080 (Ill. App. Ct. 1980)
    (person alleging agent’s authority must prove source of
    that authority). Additionally, there is no evidence that
    Morse ratified his secretary’s action with a signed docu-
    14                                               No. 01-3443
    ment referencing the May 8 letter. Prodromos, 
    560 N.E.2d at 946
    . The April and May exchange of letters, therefore,
    did not comply with the Illinois statute of frauds and
    did not form an enforceable contract, and the district
    court did not err in so finding.
    2. Applicability of the Statute of Frauds
    CDC also argues, albeit in somewhat cursory fashion, that
    the statute of frauds did not apply to the agreement be-
    tween the parties because it fully performed its obliga-
    tions under the contract. CDC asserts that it fully per-
    formed because, in accordance with its agreement with
    JMJ, it neither contacted the Rodens to seek an extension
    of its Option Agreement nor exercised the Option even
    though it had the financial ability to do so. The district
    court rejected CDC’s argument, finding that any perfor-
    mance on its part pursuant to the contract was “completely
    illusory” because its forbearance from contacting the
    Rodens was induced by forces independent of the con-
    tract and because CDC had never intended to use its
    own money to exercise the option.
    Even if we were to assume that the parties had mani-
    fested an intent to contract, we find no error with the
    district court’s conclusion that CDC did not fully perform
    its obligations. Although the Illinois statue of frauds
    does not apply to bar enforcement of a contract that has
    been completely performed by one party, B and B Land
    Acquisition, Inc. v. Mandell, 
    714 N.E.2d 58
    , 62 (Ill. App. Ct.
    1999), that party’s performance must be done “in reli-
    ance upon the agreement.” Thilman & Co. v. Esposito,
    
    408 N.E.2d 1014
    , 1021 (Ill. App. Ct. 1980); see also
    Anastaplo v. Radford, 
    153 N.E.2d 37
    , 43 (Ill. 1958); Kane
    v. Hudson, 
    112 N.E. 683
    , 684-85 (Ill. 1916) (“It is indis-
    pensable that the acts done in performance of the con-
    tract shall be referable to the contract alone, and to have
    No. 01-3443                                               15
    been done in performance of it.”). The evidence adduced
    at trial supports the district court’s finding that CDC’s
    alleged performance under the terms of the contract
    was illusory. Although CDC did not contact the Rodens to
    obtain an extension of its Option after the April and May
    1997 exchange of letters with JMJ, the evidence shows
    that its forbearance was not motivated solely by the al-
    leged contract. Cohen testified at trial that he knew as
    early as January 1997 that the Rodens would not extend
    the Option with CDC, and that in February he knew
    that the Rodens “would not under any circumstances ex-
    tend its option with” CDC. Thus, Cohen was aware even
    before the Spring 1997 exchange of letters that any at-
    tempt to contact the Rodens to extend the Option would
    be futile. Under these circumstances, the district court
    did not err in finding that CDC’s failure to contact the
    Rodens after May 1997 was not based solely on the con-
    tract and constituted illusory performance.
    Similarly, we find no error with the court’s conclusion
    that CDC’s failure to exercise its option after the Spring
    1997 exchange of letters was not motivated solely by the
    purported contract. As the court noted, CDC continued to
    pursue ways to exercise its Option even after agreeing to
    let Morse make a deal with the Rodens. For example,
    although Cohen testified at trial that CDC had the finan-
    cial ability to exercise the Option if it wanted to, the rec-
    ord also supports a finding that CDC did not find an
    acceptable way to finance the property. Although Cohen
    explored obtaining a mortgage from Best Choice Mortgage
    of Minneapolis, he testified at trial that he ultimately
    did not pursue the mortgage because it would not have
    allowed him to proceed “in a manner that was acceptable
    to the company at the time.” From this evidence the dis-
    trict court could reasonably have determined that CDC’s
    failure to contact the Rodens or exercise its Option was
    not based on its alleged contractual promise to JMJ and
    16                                           No. 01-3443
    constituted merely illusory performance. Accordingly we
    find no error with the district court’s conclusion that
    CDC did not perform all of its obligations under the con-
    tract and that the statute of frauds barred CDC’s breach
    of contract claim.
    CONCLUSION
    For the reasons set forth above, we AFFIRM the judg-
    ment of the district court.
    A true Copy:
    Teste:
    ________________________________
    Clerk of the United States Court of
    Appeals for the Seventh Circuit
    USCA-02-C-0072—1-24-03